Cargando…
Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells
BACKGROUND: Thalidomide is an immunomodulatory agent, which arrests angiogenesis. The mechanism of anti-angiogenic activity of thalidomide is not fully understood. As nitric oxide is involved in angiogenesis, we speculate a cross-talk between thalidomide and nitric oxide signaling pathway to define...
Autores principales: | Tamilarasan, KP, Kolluru, Gopi Krishna, Rajaram, Megha, Indhumathy, M, Saranya, R, Chatterjee, Suvro |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1456963/ https://www.ncbi.nlm.nih.gov/pubmed/16584574 http://dx.doi.org/10.1186/1471-2121-7-17 |
Ejemplares similares
-
Nitric oxide rescues thalidomide mediated teratogenicity
por: Siamwala, Jamila H., et al.
Publicado: (2012) -
Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing
por: Kolluru, Gopi Krishna, et al.
Publicado: (2012) -
Hydrogen Sulfide Stimulates Ischemic Vascular Remodeling Through Nitric Oxide Synthase and Nitrite Reduction Activity Regulating Hypoxia‐Inducible Factor‐1α and Vascular Endothelial Growth Factor–Dependent Angiogenesis
por: Bir, Shyamal C., et al.
Publicado: (2012) -
Nitric Oxide Reverses the Position of the Heart during Embryonic Development
por: Siamwala, Jamila H, et al.
Publicado: (2019) -
Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells
por: Kian, Mahnaz Mohammadi, et al.
Publicado: (2018)